Vorolanib

Vorolanib
Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-T8491-1mg 1 mg

7 - 10 business days*

114.00€
TGM-T8491-5mg 5 mg

7 - 10 business days*

245.00€
TGM-T8491-1mL 1 ml

7 - 10 business days*

271.00€
TGM-T8491-10mg 10 mg

7 - 10 business days*

395.00€
TGM-T8491-25mg 25 mg

7 - 10 business days*

660.00€
TGM-T8491-50mg 50 mg

7 - 10 business days*

944.00€
TGM-T8491-100mg 100 mg

7 - 10 business days*

1,281.00€
 
Description: Vorolanib (X-82) is an orally active VEGFR/PDGFR dual inhibitor. Target:... more
Product information "Vorolanib"
Description: Vorolanib (X-82) is an orally active VEGFR/PDGFR dual inhibitor. Target: PDGFR, VEGFR. Smiles: CN(C)C(=O)N1CC[C@@H](C1)NC(=O)c1c(C)[nH]c(\C=C2\C(=O)Nc3ccc(F)cc23)c1C. References: Bendell JC, et al. Phase I, First-in-Human, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Vorolanib in Patients with Advanced Solid Tumors. Oncologist. 2019 Apr,24(4):455-e121.
Keywords: CM082, X-82
Supplier: TargetMol
Supplier-Nr: T8491

Properties

Application: Multi-kinase inhibitor
MW: 439.48 D
Formula: C23H26FN5O3

Database Information

CAS : 1013920-15-4| Matching products
KEGG ID : K05089 | Matching products

Handling & Safety

Storage: -20°C
Shipping: +4°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "Vorolanib"
Write a review
or to review a product.
Viewed